Alpha Crest Capital Management LLC Bausch Health Companies Inc. Transaction History

Alpha Crest Capital Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$7.06 - $23.63 $380,618 - $1.27 Million	53,912 Added 98.48%	108,657 $908,000
Q1 2022 May 12, 2022	SELL	$21.6 - $27.79 $624,564 - $803,547	-28,915 Reduced 34.56%	54,745 $1.25 Million
Q4 2021 Feb 09, 2022	SELL	$23.0 - $29.01 $862,500 - $1.09 Million	-37,500 Reduced 30.95%	83,660 $2.31 Million
Q3 2021 Nov 10, 2021	SELL	$25.04 - $30.06 $2.87 Million - $3.45 Million	-114,635 Reduced 48.62%	121,160 $3.37 Million
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $5.91 Million - $7.05 Million	215,629 Added 1069.27%	235,795 $6.91 Million
Q1 2021 May 13, 2021	BUY	$21.37 - $34.38 $142,452 - $229,177	6,666 Added 49.38%	20,166 $640,000
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $206,685 - $285,120	13,500 New	13,500 $281,000
Q3 2020 Nov 12, 2020	SELL	$14.88 - $20.13 $787,881 - $1.07 Million	-52,949 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$13.31 - $20.51 $408,763 - $629,882	30,711 Added 138.1%	52,949 $968,000
Q1 2020 May 13, 2020	BUY	$12.98 - $30.25 $94,169 - $219,463	7,255 Added 48.42%	22,238 $345,000
Q4 2019 Feb 12, 2020	SELL	$18.89 - $31.89 $92,882 - $156,803	-4,917 Reduced 24.71%	14,983 $448,000
Q3 2019 Nov 12, 2019	SELL	$20.88 - $25.66 $60,301 - $74,106	-2,888 Reduced 12.67%	19,900 $435,000
Q2 2019 Aug 12, 2019	BUY	$20.52 - $26.45 $219,174 - $282,512	10,681 Added 88.22%	22,788 $575,000
Q1 2019 May 10, 2019	SELL	$20.23 - $26.29 $73,151 - $95,064	-3,616 Reduced 23.0%	12,107 $299,000
Q4 2018 Feb 11, 2019	BUY	$17.64 - $28.32 $277,353 - $445,275	15,723 New	15,723 $290,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.